Concepedia

Evaluating the adverse effects of melphalan formulations

Elaine Xiang, Jian Ni, Brett Glotzbecker, Jacob P. Laubach, Robert J. Soiffer, Anne McDonnell

Journal of Oncology Pharmacy Practice · 2018 · 14 citations · 12 references

DOI

Abstract

There were minimal differences in tolerability or side effects observed between PG-free MEL and PG-MEL. These data may assist in better understanding the anticipated adverse effects of a high-dose melphalan conditioning therapy.

References

12

Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics support

Paul A. Harris, Robert Taylor, Robert J. Thielke et al. · Journal of Biomedical Informatics · 2008 · 48.8K citations · Full text

, , +10

Cancer statistics, 2018

Rebecca L. Siegel, Kimberly D. Miller, Ahmedin Jemal · CA A Cancer Journal for Clinicians · 2018 · 16.8K citations · Full text

Lenalidomide, Bortezomib, and Dexamethasone with Transplantation for Myeloma

Michel Attal, Valérie Lauwers‐Cancès, Cyrille Hulin et al. · New England Journal of Medicine · 2017 · 1.2K citations · Full text

Autologous Transplantation and Maintenance Therapy in Multiple Myeloma

Antonio Palumbo, Federica Cavallo, Francesca Gay et al. · New England Journal of Medicine · 2014 · 774 citations · Full text

Propylene Glycol Toxicity: A Severe Iatrogenic Illness in ICU Patients Receiving IV Benzodiazepines

Kevin C. Wilson, Christine C. Reardon, Arthur C. Theodore et al. · CHEST Journal · 2005 · 169 citations

, , +5